Skip to main content
. 2023 Jul 20;18(10):1283–1293. doi: 10.2215/CJN.0000000000000237

Figure 4.

Figure 4

The relative risk of not being in remission at 12 months associated with anti-PLA2R antibody levels at baseline and changes in anti-PLA2R antibody and albumin levels over 3 months. The y-axis is the odds ratio for the risk not being in remission at 12 months on the basis of the multivariable model in Table 3 at the 3-month landmark time. The shaded region is the 95% confidence interval.